This review highlights the prevalence, impact on morbidity, and empirically supported somatic treatments for geriatric depression.
Alerts clinicians to geriatric depression morbidity; leaves open optimal somatic treatment selection in routine elderly care.
In light of recent statistics suggesting that geriatric depression is highly prevalent, complicates and promotes medical illness, and strongly impacts quality of life, this paper explores numerous aspects of depression in late life, including proper detection and treatment barriers, risk reduction, and somatic intervention. Additionally, the relationship between depression and morbidity is highlighted given that the prevalence of depressive symptoms increases in older adults with medical disorders and greatly impacts outcome. Finally, empirically supported somatic treatments and their side effects are discussed with emphasis on the efficacy and effectiveness of pharmacotherapy, electroconvulsive therapy (ECT), exercise, and phototherapy (bright light therapy).
No takes yet. Share an insight, caveat, or question.
Delano‐Wood et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: